RARishi Arora

Rishi Arora

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rishi Arora has a total of 267 co-authors. Here are the top co-authors by number of shared publications:

  • Anna Pfenniger

    Feinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, USA

    8 shared publications
  • Rod Passman

    Division of Cardiology, Feinberg School of Medicine, Northwestern University , 676 N St Claire, Suite 600, Chicago, IL 60611

    8 shared publications
  • Anna Pfenniger

    Northwestern University Feinberg School of Medicine

    7 shared publications
  • Bradley P. Knight

    Division of Cardiology Northwestern University Chicago Illinois USA

    7 shared publications
  • Gary L. Aistrup

    Masonic Medical Research Institute, Utica, NY (G.L.A.).

    7 shared publications
  • J. Andrew Wasserstrom

    Feinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

    7 shared publications

Latest Publications

  • Open Access

    Atrial Fibrillation and Primary Cilia-Associated Genes: The Role of CEP68

    by Zhenyu Dong, Rushd F. M. Al-Shama, Nicoline W. E. van Den Berg, Makiri Kawasaki, Marc M. Terpstra, Nerea Arrarte Terreros, Elise L. Hulsman, Aldo Jongejan, Rishi A. Arora, Wim Jan P. van Boven, et al.

    Recent studies have demonstrated that primary cilia not only play a role in cardiovascular development, but also in the progression of acquired heart disease. Their role in atrial fibrillation (AF) is incompletely understood. We hypothesize that there is a causal link between primary cilia genes and the occurrence of AF. We integrated AF GWAS data with various multi-omic datasets—including data on gene expression, DNA methylation, and protein expression quantitative trait loci (eQTL, mQTL, and pQTL)—from human left atrial appendage (LAA) tissues and blood. Genetic variants linked to primary cilia-related genes were used as instrumental variables to explore their causal links to AF, through summary-data-based Mendelian randomization (SMR) and Bayesian colocalization. Single-cell sequencing data were used to analyze the expression of the selected genes across different cell types. The mechanisms by which the selected genes exert their effects were explored using RNA sequencing data, clinical indicators, and immunohistochemical markers from 22 patients without AF from the PREDICT-AF cohort, and 21 patients with paroxysmal AF and 19 patients with persistent AF from the MARK-AF cohort. Through SMR analyses, we established significant associations between predicted CEP68 expression and AF in both blood (OR 1.25; 95% CI 1.18–1.33; false discovery rate (FDR) = 1.81 × 10−9) and LAA tissue (OR 1.12; 95% CI 1.08–1.16; FDR = 6.18 × 10−9). Moreover, predicted methylation of CEP68 showed an inverse relationship with AF risk (OR 0.87; 95% CI 0.84–0.90; FDR = 2.55 × 10−15). Colocalization results for CEP68 in both blood and the LAA indicated strong evidence of a shared causal variant. Within single-cell data, compared to the control group, AF patients had higher levels of CEP68 in fibroblasts (p = 0.046). In bulk RNA-seq data, CEP68 expression showed no significant differences among the no AF, paroxysmal AF, and persistent AF groups. CEP68 was positively correlated with the cardiac remodeling marker Thrombospondin-2 in 22 patients without AF from the PREDICT-AF cohort (r = 0.45, p = 0.03). In AF patients from the MARK-AF study, CEP68 was also positively associated with LAVI (r = 0.34, p = 0.03). Collectively, our results support a model in which genetically predicted CEP68 regulation is linked to AF liability and is consistent with fibroblast activation and remodeling-related pathways as potential mediators.


  • Open Access

    Gene Therapies in Atrial Fibrillation

    by Cian O’dOnnell, Aleksei Mikhailov, Shin Yoo, Asish Ghosh, Rishi Arora

    Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, yet current therapies—including drugs and catheter ablation—remain suboptimal. Gene therapy offers a promising way to modulate AF’s molecular drivers. This review summarizes recent preclinical studies using viral and non-viral vectors, atrial-specific delivery strategies, and key targets such as ion channels, fibrosis, and oxidative stress. Despite promising results, no AF gene therapy has FDA approval, due to challenges in atrial targeting, immune control, and durable expression. Closing this translational gap is critical for future AF gene therapy. Graphical Abstract Gene therapy for atrial fibrillation leverages viral and non-viral vectors to address targets including fibrosis, ion channels, and oxidative stress.


  • Top Cited Papers

    Millimetre-scale bioresorbable optoelectronic systems for electrotherapy

    by Yamin Zhang, Eric Rytkin, Liangsong Zeng, Jong Uk Kim, Lichao Tang, Haohui Zhang, Aleksei Mikhailov, Kaiyu Zhao, Yue Wang, Li Ding, et al.

    Temporary pacemakers are essential for the care of patients with short-lived bradycardia in post-operative and other settings1,2,3,4. Conventional devices require invasive open-heart surgery or less invasive endovascular surgery, both of which are challenging for paediatric and adult patients5,6,7,8. Other complications9,10,11 include risks of infections, lacerations and perforations of the myocardium, and of displacements of external power supplies and control systems. Here we introduce a millimetre-scale bioresorbable optoelectronic system with an onboard power supply and a wireless, optical control mechanism with generalized capabilities in electrotherapy and specific application opportunities in temporary cardiac pacing. The extremely small sizes of these devices enable minimally invasive implantation, including percutaneous injection and endovascular delivery. Experimental studies demonstrate effective pacing in mouse, rat, porcine, canine and human cardiac models at both single-site and multi-site locations. Pairing with a skin-interfaced wireless device allows autonomous, closed-loop operation upon detection of arrhythmias. Further work illustrates opportunities in combining these miniaturized devices with other medical implants, with an example of arrays of pacemakers for individual or collective use on the frames of transcatheter aortic valve replacement systems, to provide unique solutions that address risks for atrioventricular block following surgeries. This base technology can be readily adapted for a broad range of additional applications in electrotherapy, such as nerve and bone regeneration, wound therapy and pain management.


  • Open Access

    Association between high‐density mapping of atypical atrial flutter, clinical outcomes and healthcare utilization

    by Joshua Sink, Kasen Culler, Lakshmi Uppalapati, Nicola Lancki, Graham Peigh, Graham Lohrmann, Mahmoud Elsayed, Herman Carneiro, Jayson Baman, Anna Pfenniger, et al.

    Background: Success of atypical atrial flutter (AAFL) ablation has historically been limited by difficulty mapping the complex re‐entrant circuits involved. While high‐density (HD) mapping has become commonplace in clinical practice, there are limited data on outcomes of HD versus non‐HD mapping for AAFL ablation.Objective: To compare clinical outcomes and healthcare utilization using HD mapping versus non‐HD mapping for AAFL ablation.Methods: Retrospective analysis of all AAFL procedures between 2005 and 2022 at an academic medical center was conducted. Procedures utilizing a 16‐electrode HD Grid catheter and Precision mapping system were compared to procedures using prior generation 10–20 electrode spiral catheters and the Velocity system (Abbott, IL). Cox regression models and Poisson regression models were utilized to examine procedural and healthcare utilization outcomes. Models were adjusted for left ventricular ejection fraction, CHA2DS2‐VASc, and history of prior ablation.Results: There were 108 patients (62% HD mapping) included in the analysis. Baseline clinical characteristics were similar between groups. Use of HD mapping was associated with a higher rate of AAFL circuit delineation (92.5% vs. 76%; p = .014) and a greater adjusted procedure success rate, defined as non‐inducibility at procedure end, (aRR (95% CI) 1.26 (1.02–1.55) p = .035) than non‐HD mapping. HD mapping was also associated with a lower rate of ED visits (aIRR (95% CI) 0.32 (0.14–0.71); p = .007) and hospitalizations (aIRR (95% CI) 0.32 (0.14–0.68); p = .004) for AF/AFL/HF through 1 year. While there was a lower rate of recurrent AFL through 1 year among HD mapping cases (aHR (95% CI) 0.60 (0.31–1.16) p = .13), statistical significance was not met likely due to the low sample size and higher rate of ambulatory rhythm monitoring in the HD group (61% vs. 39%, p = .025).Conclusion: Compared to non‐HD mapping, AAFL ablation with HD mapping is associated with improvements in the ability to define the AAFL circuit, greater procedural success, and a reduction in the number of ED visits and hospitalization for AF/AFL/HF.


  • Open Access

    In Vivo Mapping of Myocardial Injury Outside the Infarct Zone: Tissue at an Intermediate Pathological State

    by Kaixi Ren, Songwang Hou, Steven E. Johnson, Jon Lomasney, Chad R. Haney, Jungwha Lee, Zhi‐Dong Ge, Daniel C. Lee, Jeffrey J. Goldberger, Rishi Arora, et al.

    Background: The goal was to determine the feasibility of mapping the injured‐but‐not‐infarcted myocardium using 99m Tc‐duramycin in the postischemic heart, with spatial information for its characterization as a pathophysiologically intermediate tissue, which is neither normal nor infarcted. Methods and Results: Coronary occlusion was conducted in Sprague Dawley rats with preconditioning and 30‐minute ligation. In vivo single‐photon emission computed tomography was acquired after 3 hours (n=6) using 99m Tc‐duramycin, a phosphatidylethanolamine‐specific radiopharmaceutical. The 99m Tc‐duramycin + areas were compared with infarct and area‐at‐risk (n=8). Cardiomyocytes and endothelial cells were isolated for gene expression profiling. Cardiac function was measured with echocardiography (n=6) at 4 weeks. In vivo imaging with 99m Tc‐duramycin identified the infarct (3.9±2.4% of the left ventricle and an extensive area 23.7±2.2% of the left ventricle) with diffuse signal outside the infarct, which is pathologically between normal and infarcted (apoptosis 1.8±1.6, 8.9±4.2, 13.6±3.8%; VCAM‐1 [vascular cell adhesion molecule 1] 3.2±0.8, 9.8±4.1, 15.9±4.2/mm 2 ; tyrosine hydroxylase 14.9±2.8, 8.6±4.4, 5.6±2.2/mm 2 ), with heterogeneous changes including scattered micronecrosis, wavy myofibrils, hydropic change, and glycogen accumulation. The 99m Tc‐duramycin + tissue is quantitatively smaller than the area‐at‐risk (26.7% versus 34.4% of the left ventricle, P =0.008). Compared with infarct, gene expression in the 99m Tc‐duramycin + –noninfarct tissue indicated a greater prosurvival ratio (BCL2/BAX [B‐cell lymphoma 2/BCL2‐associated X] 7.8 versus 5.7 [cardiomyocytes], 3.7 versus 3.2 [endothelial]), and an upregulation of ion channels in electrophysiology. There was decreased contractility at 4 weeks (regional fractional shortening −8.6%, P P <0.05). Conclusions: The injured‐but‐not‐infarcted tissue, being an intermediate zone between normal and infarct, is mapped in vivo using phosphatidylethanolamine‐based imaging. The intermediate zone contributes significantly to cardiac dysfunction.


  • Open Access

    Use of Atrial Fibrillation Electrograms and T1/T2 Magnetic Resonance Imaging to Define the Progressive Nature of Molecular and Structural Remodeling: A New Paradigm Underlying the Emergence of Persistent Atrial Fibrillation

    by Markus Rottmann, Shin Yoo, Anna Pfenniger, Aleksei Mikhailov, Brandon Benefield, David A. Johnson, Wenwei Zhang, Asish K. Ghosh, Daniel Kim, Rod Passman, et al.

    Background: The temporal progression states of the molecular and structural substrate in atrial fibrillation (AF) are not well understood. We hypothesized that these can be detected by AF electrograms and magnetic resonance imaging parametric mapping. Methods and Results: AF was induced in 43 dogs (25–35 kg, ≥1 year) by rapid atrial pacing (RAP) (3–33 weeks, 600 beats/min), and 4 controls were used. We performed high‐resolution epicardial mapping (UnEmap, 6 atrial regions, both atria, 130 electrodes, distance 2.5 mm) and analyzed electrogram cycle length, dominant frequency, organization index, and peak‐to‐peak bipolar voltage. Implantable telemetry recordings were used to quantify parasympathetic nerve activity over RAP time. Magnetic resonance imaging native T1, postcontrast T1, T2 mapping, and extracellular volume fraction were assessed (1.5T, Siemens) at baseline and AF. In explanted atrial tissue, DNA oxidative damage (8‐hydroxy‐2′‐deoxyguanosine staining) and percentage of fibrofatty tissue were quantified. Cycle length and organization index decreased ( R =0.5, P R =0.5, P R =0.3, P n.s.) until 80 days of RAP but not thereafter. In contrast, voltage continued to decrease throughout the duration of RAP ( R =0.6, P R =0.5, P R =0.6, P R =0.5, P <0.05 for both). Conclusions: A combination of AF electrogram characteristics and T1/T2 magnetic resonance imaging can detect early‐stage AF remodeling (autonomic remodeling, oxidative stress) and advanced AF remodeling due to oxidative stress and fibrosis.


  • Open Access

    Comparison of electrogram characteristics in persistent atrial fibrillation

    by Jeffrey J. Goldberger, Ghaith Zaatari, Raul D. Mitrani, Catherine Blandon, Jorge Bohorquez, Jason Ng, Justin Ng, Alex Velasquez, Litsa Lambrakos, Rishi Arora

    Introduction: Multiple analysis techniques evaluate electrograms during atrial fibrillation (AF), but none have been established to guide catheter ablation. This study compares electrogram properties recorded from multiple right (RA) and left atrial (LA) sites.Methods: Multisite LA/RA mapping (281 ± 176/239 ± 166 sites/patient) was performed in 42 patients (30 males, age 63 ± 9 years) undergoing first (n = 32) or redo‐AF ablation (n = 10). All electrogram recordings were visually reviewed and artifactual signals were excluded leaving a total of 21 846 for analysis. Electrogram characteristics evaluated were cycle length (CL), amplitude, Shannon's entropy (ShEn), fractionation interval, dominant frequency, organizational index, and cycle length of most recurrent morphology (CLR) from morphology recurrence plot analysis.Results: Electrogram characteristics were correlated to each other. All pairwise comparisons were significant (p < .001) except for dominant frequency and CLR (p = .59), and amplitude and dominant frequency (p = .38). Only ShEn and fractionation interval demonstrated a strong negative correlation (r = −.94). All other pairwise comparisons were poor to moderately correlated. The relationships are highly conserved among patients, in the RA versus LA, and in those undergoing initial versus redo ablations. Antiarrhythmic drug therapy did not have a significant effect on electrogram characteristics, except minimum ShEn. Electrogram characteristics associated with ablation outcome were shorter minimum CLR, lower minimum ShEn, and longer mimimum CL. There was minimal overlap between the top 10 sites identified by one electrogram characteristic and the top 10 sites identified by the other 10 characteristics.Conclusion: Multiple techniques can be employed for electrogram analysis in AF. In this analysis of eight different electrogram characteristics, seven were poorly to moderately correlated and do not identify similar locations. Only some characteristics were predictive of ablation outcome. Further studies to consider electrogram properties, perhaps in combination, for categorizing and/or mapping AF are warranted.


  • Top Cited Papers

    A transient, closed-loop network of wireless, body-integrated devices for autonomous electrotherapy

    by Yeon Sik Choi, Hyoyoung Jeong, Rose T. Yin, Raudel Avila, Anna Pfenniger, Jaeyoung Yoo, Jong Yoon Lee, Andreas Tzavelis, Young Joong Lee, Sheena W. Chen, et al.

    Temporary postoperative cardiac pacing requires devices with percutaneous leads and external wired power and control systems. This hardware introduces risks for infection, limitations on patient mobility, and requirements for surgical extraction procedures. Bioresorbable pacemakers mitigate some of these disadvantages, but they demand pairing with external, wired systems and secondary mechanisms for control. We present a transient closed-loop system that combines a time-synchronized, wireless network of skin-integrated devices with an advanced bioresorbable pacemaker to control cardiac rhythms, track cardiopulmonary status, provide multihaptic feedback, and enable transient operation with minimal patient burden. The result provides a range of autonomous, rate-adaptive cardiac pacing capabilities, as demonstrated in rat, canine, and human heart studies. This work establishes an engineering framework for closed-loop temporary electrotherapy using wirelessly linked, body-integrated bioelectronic devices.


  • Open Access

    602 Child protection medical assessments (CPMA) during first lockdown- comparison with previous year

    by Tapomay Banerjee, Sreha Pokharel, Rishi Arora, Oseiwa Kwapong, Andrea Aniwell

    Background COVID 19 pandemic has caused significant disruption in healthcare and social services nationwide and probably all over the planet. Various national and international agencies have raised concerns that perpetrators may take advantage of school closure and lockdown. Initial reports also have suggested that there was a nationwide increase in number of young infants admitted with abusive head trauma but generally a decrease in CPMA referrals during the first nationwide lockdown in summer 2020. Objectives Objective of our study is to look at the impact of COVID-19 related first lockdown on CPMA referral numbers in Bedford. Paediatric team at Bedford hospital does CPMAs for physical abuse in children who are under the age of 2 years and children presenting in out of hours. Rest of the CPMAs for physical abuse and neglect medicals for all ages are seen at Bedford Community Paediatric services. Methods We looked at total number of CPMA done at Bedford hospital and Bedford community paediatric services between 01/04/2020 to 30/09/2020(6 months). Total number of CPMA for physical abuse and neglect were collected and compared with numbers during same time period in 2019. Results Number of CPMAs due to neglect was up by 178% when compared to same time frame in 2019 but number of physical abuse was down by 25%. Overall, total number of children who had CPMAs in Bedford was more (12.2%) increase in April to September in 2020 in comparison to 2019 (table 1). There was not much increase in number CPMAs done in children under 2 years of age (4% increase only - 26 in 2020 April to September and 25 in same time frame in 2019). Conclusions We have seen a decrease in referrals for physical abuse but more CPMAs were done during this period for neglect. There was no significant increase in number of CPMAs done in children less than 2 years of age. This is an interesting observation and further research and data collection should be encouraged to see the national trend.